	Ebitda		Date
AbbVie	USD 3.52B	828M	2025-09
Alcon AG	USD 654M	404M	2025-09
Amgen	USD 5.14B	775M	2025-12
argenx SE	USD 288.02M	84.53M	2025-06
AstraZeneca	USD 5.23B	272M	2025-09
Bayer	EUR 1.51B	1.28B	2025-09
Biogen	USD 573.2M	253.7M	2025-12
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Eli Lilly	USD 7.88B	378.1M	2025-09
Fresenius	EUR 850M	22M	2025-09
Fresenius Medical Care	EUR 931.26M	60.26M	2025-09
Galapagos	EUR -158.71M	177.84M	2025-03
Genmab	DKK 477M	101M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Glaxosmithkline	GBP 4.75B	1.52B	2025-09
GRIFOLS	EUR 347.24M	58.35M	2025-06
Hikma Pharmaceutical	USD 369M	84M	2024-12
Lonza	CHF 1.01B	54M	2025-12
Merck	EUR 1.46B	45M	2025-06
Merck	USD 8.39B	1.97B	2025-09
Novartis	USD 5.88B	290M	2025-09
Novo Nordisk	DKK 37.3B	5.86B	2025-12
Orion	EUR 343M	207.9M	2025-12
Pfizer	USD 6.08B	351M	2025-09
Philips	EUR 738M	9M	2025-09
Recordati	EUR 247.57M	21.38M	2025-09
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sanofi	EUR 4.84B	2.95B	2025-09
Smith & Nephew	USD 796M	139M	2025-12
UCB	EUR 1.03B	334M	2025-06

GlaxoSmithKline - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.